Beijing Beilu Pharmaceutical Co (SZSE:300016) Long-Term Capital Lease Obligation : ¥0 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Long-Term Capital Lease Obligation?

Beijing Beilu Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥0 Mil.

Beijing Beilu Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (¥6 Mil) to Dec. 2024 (¥5 Mil) and declined from Dec. 2024 (¥5 Mil) to Mar. 2025 (¥0 Mil).

Beijing Beilu Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥10 Mil) to Dec. 2023 (¥7 Mil) and declined from Dec. 2023 (¥7 Mil) to Dec. 2024 (¥5 Mil).

Beijing Beilu Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.14

9.98

7.17

4.80

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															5.65	6.38	5.63	4.80	0.25

Beijing Beilu Pharmaceutical Co (SZSE:300016) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Beijing Beilu Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines